NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Core Viewpoint - A class action lawsuit has been filed against Inari Medical, Inc. for alleged violations of securities laws, specifically related to misleading statements about the company's financial performance and improper compensation practices [1][5]. Group 1: Lawsuit Details - The lawsuit pertains to investors who purchased Inari's securities between February 24, 2022, and February 28, 2024, during which the company allegedly made false claims about its revenue [2][5]. - The Schall Law Firm is representing the investors and encourages those who suffered losses to contact them before July 12, 2024 [2][3]. Group 2: Allegations Against Inari - The complaint alleges that Inari falsely claimed "record revenues" due to the strength of its core VTE business while actually engaging in improper compensation of medical professionals, violating federal laws [5]. - The misleading public statements made by Inari resulted in significant damages to investors once the truth was revealed [5].